from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2344c/dgt

LFCtreatmentdescriptionclass of inhibitor

-1.299

Amikacinug/mL Amikacintranslation

-0.522

Cap5-10ug/mL Capreomycintranslation

-0.308

Rox10-50 ug/mL Roxithromycintranslation

-0.237

SM2-5 ug/mL Streptomycintranslation

3.794

Tet5-10 ug/mL Tetracyclinetranslation

0.894

Rif0.2-5ug/mL Rifampicintranscription

0.817

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.251

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.322

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.003

CPZ10-50 ug/mL Chlorpromazinerespiration

0.002

Clofazimine10-13 ug/mL Clofaziminerespiration

0.090

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.833

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.943

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.477

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.522

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.529

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.323

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.197

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.909

KCN5-20 ug/mL Potassium cyaniderespiration

-1.081

NaN30.2-2 mM Sodium aziderespiration

0.037

Nigericin50 uM Nigericinrespiration

0.046

TRC10-150 ug/mL Triclosanrespiration

-1.160

TRZ10-25 ug/mL Thioridazinerespiration

-0.084

Valinomycin0.5-10 uM Valinomycinrespiration

-3.049

ZnSO42 mM ZnSO4respiration

-0.425

menadione6-10 ug/mL Menadionerespiration

-0.186

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.086

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.138

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.698

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.763

NRP_1Non-replicating persistence stage 1dosRassociated

0.144

Amp0.2mg/mL AmpicillincellWall

0.231

Cephalexin20-100 ug/mL CephalexincellWall

0.388

Cerulenin0.32-5 ug/mL CerulenincellWall

0.270

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.159

EMB10-20 ug/mL EthambutolcellWall

-0.321

Eta12-40 ug/mL EthionamidecellWall

0.467

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.593

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.856

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.555

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.365

BZA0.12 mg/mL BenzamidearomaticAmides

0.701

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.459

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.553

H2O24 mM hydrogen peroxideDNAdamaging

0.026

Levo10 ug/mL LevofloxacinDNAdamaging

0.494

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.015

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.383

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.193

UVUV-irradiationDNAdamaging

-0.102

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.359

Antimycin12.5-50 ug/mL Antimycin A?

-0.391

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.212

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.209

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.404

PA8240.2-2 ug/mL PA-824?

0.884

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.405

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.484

Verapamil50 uM Verapamil?

-0.836

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.312

methoxatin10-20 ug/mL Methoxatin?